TELO ▲ +1.7% - Telomir Pharmaceuticals, Inc. $TELO - Telomir Announces Research with The Ohio State University Demonstrating In-Vitro Anti-Cancer Activity in Human and Canine Osteosarcoma Models Telomir Pharmaceuticals (TELO) rose 1.7% today following an announcement of research conducted with The Ohio State University showing in-vitro anti-cancer activity against human and canine osteosarcoma models. The positive preclinical data in osteosarcoma, a serious bone cancer, appeared to support investor optimism about the company's therapeutic approach. 14-SEP-2026 08:00 AM ET